Cytek share price
WebJul 19, 2024 · Cytek Biosciences, Inc. Common Stock (CTKB) Stock Price, Quote, News & History Nasdaq Cytek Biosciences, Inc. Common Stock (CTKB) Add to Watchlist Add … WebFeb 21, 2024 · Cytek Biosciences Inc’s Stock Price as of Market Close. As of February 21, 2024, 4:00 PM CST, Cytek Biosciences Inc’s stock price was $10.97. Cytek Biosciences Inc is down 4.94% from its previous closing price of $11.54. During the last market session, Cytek Biosciences Inc’s stock traded between $11.52 and $11.85.
Cytek share price
Did you know?
WebBy making bigger panels possible, spectral flow cytometry provides researchers more information from one tube and reduces the amount of tubes needed in an assay. This saves precious sample and reagent, reduces sample preparation and acquisition time, and reduces operating costs, allowing labs to run more efficiently. WebFeb 17, 2024 · As of Tuesday, February 14, Cytek Biosciences Inc’s CTKB share price has dipped by 8.77%, which has investors questioning if this is right time to buy. Jenna Brashear. Stock Grade Focus Is Cytek Biosciences Inc (CTKB) Stock a Good Investment? Learn more about Cytek Biosciences Inc's (CTKB) stock grades for Value, Momentum, …
WebJul 22, 2024 · Cytek intends to raise $248 million in gross proceeds from an IPO of its common stock, offering 14.6 million shares at a proposed midpoint price of $17.00 per share. WebOct 14, 2024 · Hence, if weakness in Cytek Biosciences' share price continues, institutional investors may feel compelled to sell the stock, which might not be ideal for individual investors.
WebJul 19, 2024 · Cytek Biosciences, Inc. Common Stock (CTKB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebApr 5, 2024 · Price *Price Target Lowest: 11.00 Median: 17.00 Highest: 28.00 *The average price target includes all analyst analysis, not just the most recent analysis presented in …
WebApr 8, 2024 · The data shows that as of Mar 14, 2024 short interest in Cytek Biosciences Inc. (CTKB) stood at 4.28% of shares outstanding, with shares short rising to 5.49 million registered in Feb 14, 2024. Current price change has pushed the stock -12.05% YTD, which shows the potential for further growth is there. It is this reason that could see investor ...
WebCytek Biosciences is registered under the ticker NASDAQ:CTKB . Their stock opened with $17.00 in its Jul 23, 2024 IPO. Stock Symbol NASDAQ:CTKB Valuation at IPO $2.2B … crystal park benoni rentalsWebJul 27, 2024 · Cytek Biosciences, Inc. FREMONT, Calif., July 27, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions ... dye hair red with teaWebApr 13, 2024 · Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CEO Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock in a transaction that occurred on Monday, April 10th.The stock was sold at an average price of $8.88, for a total transaction of $177,600.00. Following the sale, the chief executive officer now owns 7,684,439 shares … crystal park benoni housesWebApr 11, 2024 · The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. Cytek Biosciences Inc Stock Price History. Cytek Biosciences Inc’s price is currently up 3.92% so far this month. During the month of April, Cytek Biosciences Inc’s stock price has reached a high of ... crystal park benoni mapWebFeb 27, 2024 · As of February 27, 2024, 4:00 PM CST, Cytek Biosciences Inc’s stock price was $10.54. Cytek Biosciences Inc is down 5.56% from its previous closing price of $11.16. During the last market session, Cytek Biosciences Inc’s stock traded between $10.80 and $11.21. Currently, there are 134.71 million shares of Cytek Biosciences Inc stock ... dye hair reddish purpleWebFeb 3, 2024 · See the latest Cytek Biosciences Inc stock price (NASDAQ:CTKB), related news, valuation, dividends and more to help you make your investing decisions. crystal park californiaWebApr 6, 2024 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Cytek Biosciences stock is Moderate Buy based on the current 1 hold rating … dye hairstyles 2016